Jiangxi Fushine Pharmaceutical News

Fuxiang Pharmaceutical (300497): The potential of alternative proteins is showing, and the future is expected to open up room for growth

Guotou SecuritiesJul 15, 2024 00:00

Fuxiang Pharmaceutical (300497): Actively deploying CDMO and new materials based on APIs to embark on a new journey of growth

安信證券Nov 10, 2022 16:56

Fuxiang Pharmaceutical (300497) event comments: the price of sulbactam rebounded CDMO opens room for long-term growth

國海證券Aug 23, 2021 00:00

Fuxiang Pharmaceutical (300497): performance is expected to improve marginally and focus on the pace of new capacity release

開源證券Aug 12, 2021 00:00

Fuxiang Pharmaceutical (300497) semi-annual report comments: the company's performance is under short-term pressure on products under research + capacity release to boost growth

平安證券Aug 12, 2021 00:00

Fuxiang Pharmaceutical (300497): the Integration Strategy of Industry chain steadily promotes the Development of CDMO Business

長城國瑞證券Apr 27, 2021 00:00

Fuxiang Pharmaceutical Co., Ltd. (300497): 2020 performance before high and low after cooperation with Kailing Pharmaceutical to speed up the layout of CDMO

平安證券Apr 25, 2021 00:00

Fuxiang Pharmaceutical (300497) 2020 and 2021Q1 Financial report comments: price increase of core products CDMO cooperation adds new growth momentum

國海證券Apr 25, 2021 00:00

富祥药业(300497)2020年三季报点评：业绩符合预期 持续推进长期战略

西南證券Nov 8, 2020 00:00

富祥药业(300497)季报点评：疫情导致下游库存增加 影响Q3业绩表现

平安證券Oct 29, 2020 00:00

富祥药业(300497)：Q3受停产检修等因素影响 未来产能将持续提升

太平洋證券Oct 28, 2020 00:00

富祥药业(300497)事件点评：疫情因素扰动三季度业绩增速 新产能依次落地奠定长期成长性

國海證券Oct 28, 2020 00:00

富祥药业(300497)季报点评：Q3去库存影响业绩 持续推进定增拓展产业一体化

天風證券Oct 28, 2020 00:00

富祥药业(300497)：特色抗菌原料药生产企业 打造“医药中间体-原料药-制剂一体化”

長城國瑞證券Aug 27, 2020 00:00

富祥药业(300497)：Β-内酰胺酶抑制剂龙头企业 业务拓展增添新的成长动能

開源證券Aug 6, 2020 00:00

富祥药业(300497)：业绩表现良好 高端抗生素业务稳增长

西南證券Aug 6, 2020 00:00

富祥药业(300497)：业绩超预期 产业链一体化稳步推进

東北證券Aug 4, 2020 00:00

富祥药业(300497)：上半年业绩高增长 继续推进定增拓展产业链布局

天風證券Aug 3, 2020 00:00

富祥药业(300497)：主力品种量价齐升 纵横双向拓展稳步推进

光大證券Aug 3, 2020 00:00

富祥药业(300497)：抗菌素原料药持续高景气 公司业绩超预期

渤海證券Aug 3, 2020 00:00